Validity of rapid free T4 testing to distinguish levothyroxine non compliance from malabsorption: a case report

Authors

  • K. Pramila Institute of Biochemistry, Madras Medical College, Chennai, Tamil Nadu, India
  • M. Vijayalakshmi Institute of Biochemistry, Madras Medical College, Chennai, Tamil Nadu, India
  • V. Amuthavalli Institute of Biochemistry, Madras Medical College, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20261454

Keywords:

Hypothyroidism, Levothyroxine, Medication adherence, Drug absorption

Abstract

Refractory hypothyroidism is characterised by persistently elevated thyroid-stimulating hormone (TSH) despite adequate or high-dose levothyroxine therapy. It presents a common clinical challenge, often requiring evaluation for causes such as poor adherence, drug interactions, or gastrointestinal malabsorption. Pseudomalabsorption due to inconsistent medication intake is the most frequent and reversible cause. Differentiating this from true malabsorption is crucial, as the latter may necessitate investigation for conditions like celiac disease, inflammatory bowel disease, or post-surgical states. The levothyroxine absorption test (LT4AT) is commonly used for this purpose, but conventional protocols are lengthy, costly, and inconvenient. Recently, simplified approaches using a single high oral dose with early measurement of serum free thyroxine (FT4) have been proposed. A rise in FT4 within a few hours indicates adequate intestinal absorption. We report a 54-year-old woman with refractory hypothyroidism in whom a short-duration LT4AT confirmed adequate absorption, suggesting pseudomalabsorption.

 

References

uiroz-Aldave JE, Concepción-Zavaleta MJ, Durand-Vásquez MDC, Concepción-Urteaga LA, Gamarra-Osorio ER, Suárez-Rojas J, et al. Refractory hypothyroidism: Unraveling the complexities of diagnosis and management. Endocr Pract. 2023;29(12):1007-16.

Santos Monteiro S, Santos TS, Lopes AM, Oliveira JC, Freitas C, Couto Carvalho A. Levothyroxine malabsorption or pseudomalabsorption? A question in the management of refractory hypothyroidism. Endocr Connect. 2022;11(12):e220355.

Caron P, Tudor C, Grunenwald S. Levothyroxine absorption test with the daily levothyroxine dose in patients with “refractory hypothyroidism. J Endocr Soc. 2025;9(4):1-6.

Amiyangoda G, Antonypillai CN, Gunatilake SSC, Weerathunge TT, Ediriweera D, Kosgallana SGPD, et al. Rapid supervised levothyroxine absorption test in refractory hypothyroidism: suggestion for assessing absorption using two blood samples in low-resource settings. Endocr Connect. 2024;13(10):e240277.

Alhassan AA, Alidrisi HA, Mansour AA. Validity of the rapid thyroxine absorption test for the differentiation between levothyroxine non-compliance and malabsorption in thyroid-stimulating hormone refractory hypothyroidism. Cureus. 2023;15(4):e37776.

Oueslati I, Terzi A, Yazidi M, Kamoun E, Feki M, Chihaoui M. Levothyroxine absorption test in patients with refractory hypothyroidism: how to interpret patient’s response to the test? Endocrine. 2025;90(1):166-71.

Downloads

Published

2026-05-04

How to Cite

Pramila, K., Vijayalakshmi, M., & Amuthavalli, V. (2026). Validity of rapid free T4 testing to distinguish levothyroxine non compliance from malabsorption: a case report. International Journal of Advances in Medicine. https://doi.org/10.18203/2349-3933.ijam20261454

Issue

Section

Case Reports